Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
MALARIA: A Renewed Assault on an Old and Deadly Foe
Eliot Marshall
After languishing for decades in the scientific backwaters, malaria research is suddenly being swept into the mainstream. Money is beginning to pour in from international finance and aid organizations, giving researchers who have been doggedly pursuing an intractable foe with limited resources the means to follow new leads. But on the ground, the disease is unyielding, and the current weapons are losing their effectiveness.
In a series of related stories, Science explores the World Health Organization's crusade that aims to cut malaria mortality in half over the next 10 years, conditions on the front lines of clinical research in Africa, the challenges that have slowed development of a so-far elusive vaccine, renewed interest in a Chinese herbal remedy that could aid in the fight against drug-resistant malaria, progress in attacking the Plasmodium parasite through its genome, and the dream of building a malaria-proof mosquito.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
NEWS FOCUS
Ann Gibbons (27 April 2001) Science292 (5517), 627.
[DOI: 10.1126/science.292.5517.627] |Summary »|Full Text »
NEWS FOCUS
Michael Balter (20 October 2000) Science290 (5491), 430.
[DOI: 10.1126/science.290.5491.430] |Summary »|Full Text »
NEWS FOCUS
Gretchen Vogel (20 October 2000) Science290 (5491), 431.
[DOI: 10.1126/science.290.5491.431] |Summary »|Full Text »
NEWS FOCUS
Gretchen Vogel (20 October 2000) Science290 (5491), 432.
[DOI: 10.1126/science.290.5491.432] |Summary »|Full Text »
NEWS FOCUS
Gary Taubes (20 October 2000) Science290 (5491), 434.
[DOI: 10.1126/science.290.5491.434] |Summary »|Full Text »
NEWS FOCUS
Gary Taubes (20 October 2000) Science290 (5491), 435.
[DOI: 10.1126/science.290.5491.435] |Summary »|Full Text »
NEWS FOCUS
Eliot Marshall (20 October 2000) Science290 (5491), 437.
[DOI: 10.1126/science.290.5491.437] |Summary »|Full Text »
NEWS FOCUS
Elizabeth Pennisi (20 October 2000) Science290 (5491), 439.
[DOI: 10.1126/science.290.5491.439] |Summary »|Full Text »
NEWS FOCUS
Martin Enserink (20 October 2000) Science290 (5491), 440.
[DOI: 10.1126/science.290.5491.440] |Summary »|Full Text »
REPORTS
Henrik Kaessmann, Victor Wiebe, and Svante Pääbo (5 November 1999) Science286 (5442), 1159.
[DOI: 10.1126/science.286.5442.1159] |Abstract »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccine Encoding Thrombospondin-Related Adhesion Protein but Not Circumsporozoite Protein Partially Protects Healthy Malaria-Naive Adults against Plasmodium falciparum Sporozoite Challenge..
S. J. Dunachie, M. Walther, J. E. Epstein, S. Keating, T. Berthoud, L. Andrews, R. F. Andersen, P. Bejon, N. Goonetilleke, I. Poulton, et al. (2006)
Infect. Immun.
74, 5933-5942
|Abstract »|Full Text »|PDF »
Safety, Immunogenicity, and Efficacy of Prime-Boost Immunization with Recombinant Poxvirus FP9 and Modified Vaccinia Virus Ankara Encoding the Full-Length Plasmodium falciparum Circumsporozoite Protein..
M. Walther, F. M. Thompson, S. Dunachie, S. Keating, S. Todryk, T. Berthoud, L. Andrews, R. F. Andersen, A. Moore, S. C. Gilbert, et al. (2006)
Infect. Immun.
74, 2706-2716
|Abstract »|Full Text »|PDF »
Prime-boost strategies for malaria vaccine development.
Population Structure of Anopheles gambiae in Africa.
T. Lehmann, M. Licht, N. Elissa, B. T. A. Maega, J. M. Chimumbwa, F. T. Watsenga, C. S. Wondji, F. Simard, and W. A. Hawley (2003)
J. Hered.
94, 133-147
|Abstract »|Full Text »|PDF »